Information for activists, patients, health workers & researchers working to end tuberculosis
Website of the Global Tuberculosis Community Advisory Board
By Kelly M. Percival, PharmD, BCPS-AQ ID Published: May 20, 2022, 7:26 p.m.· Tags: Drug-resistant TB, Treatment
In February, the CDC released provisional guidance for the use of pretomanid as part of the bedaquiline, pretomanid and linezolid (BPaL) regimen to treat drug-resistant tuberculosis.
Read More →
Page 1 of 1 · Total posts: 1
